The effect of butyrate, a natural bacterial product of colonic bacterial flora, on lipopolysaccharide (LPS)-induced nitric oxide (NO) production in RAW 264.7 murine macrophage cells was studied. Butyrate significantly reduced NO production in LPS-stimulated RAW cells. The inhibition was abolished by the removal of butyrate. Butyrate also inhibited the expression of inducible type NO synthase (iNOS) in LPS-stimulated RAW cells. Furthermore, butyrate prevented the activation of nuclear factor (NF)-κB through the stabilization of IκB-α and IκB-β. Butyrate did not affect the phosphorylation of mitogen-activated protein (MAP) kinases by LPS. It was, therefore, suggested that butyrate down-regulated LPS-induced NO production in RAW cells through preventing the expression of iNOS, and that it was due to the inhibitory action of butyrate on the activation of NF-κB.
References
1.
Cummings JH, Pomare EW, Branch WJ et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut1987; 28: 1221—1227.
2.
Treem WR, Ahsan N., Shoup M., Hyams J.Fecal short chain fatty acids in children with inflammatory bowel disease . J Pediatr Gastroenterol Nutr1994; 18: 159—164.
3.
Dabard J., Hudault S., Saby MA et al. Production of butyric acid in human premature baby suffering from necrotizing enterocolitis. Proceedings of the 9th International Symposium on Gnotobiology, Versailles, 1987; 90—95.
4.
Fukushima K. , Sasaki I., Takahashi K. et al. Lipopolysaccharide exhibits synergistic enhancement of butyrate-induced and retinoic acid mediated alkaline phosphatase activity on small intestinal epithelial cell line, IEC-6. Digestion1998; 59: 683—688.
5.
Perez R., Stevenson F., Johnson J. et al. Sodium butyrate upregulates Kupffer cells by PEG2 production and modulates immune function. J Surg Res1998; 78: 1—6.
6.
Fusunyan RD, Quinn JJ, Ohno Y. et al. Butyrate enhances interleukin (IL)-8 secretion by intestinal epithelial cells in response to IL-1β and lipopolysaccharide. Pediatr Res1998; 43: 84—90.
7.
Tsuneoka K., Shikita M.A colony-stimulating factor for neutrophil granulocytes: a marked increase of its production by the addition of sodium butyrate and lipopolysaccharide in serum-free culture of RSP-2 X P3 cells. J Cell Physiol1985; 125: 436—442.
8.
Wang LS, Chow KC, Wu CWExpression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate. Br J Cancer1999; 80: 1617—1622.
9.
Moulding DA, Quayle JA, Hart CA, Edwards SWMcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood92: 2495—2502.
10.
Ohno Y., Lee J., Fusunyan RD et al. Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells. Proc Natl Acad Sci USA1997; 94: 10279—10284.
11.
Beckman JS, Koppenol WHNitric oxide, super oxide, and peroxynitrite: the good, the bad, and the ugly . Am J Physiol1996; 271: C1424—C1437.
12.
Dimmeler S. , Zeiher AMNitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric OxideBiol Chem1997; 1: 275—281.
13.
Kroncke KD, Fehsel K., Kolb-Bachofen V.Nitric oxide: cytotoxicity versus cytoprotection — how, why, when and where? Nitric OxideBiol Chem1997; 1: 107—120.
14.
MacMicking J., Xie QW, Nathan C.Nitric oxide and macrophage function. Annu Rev Immunol1997; 15: 323—350.
15.
Green LC, Wagner Dda, Glowgowski J. et al. Analysis of nitrate, nitrite and 15N nitrate in biological fluids . Anal Biochem1982; 1236: 131—138.
16.
Kato Y., Kravchenko VV, Tapping RI et al. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J1997; 16: 7054—7066.
17.
de las Heras B., Navarro A., Diaz-Guerra MJ et al. Inhibition of NOS-2 expression in macrophages through the inactivation of nuclear factor-kappa B by andalusol. Br J Pharmacol1999; 128: 605—612.
18.
Delgado M., Munoz-Elias EJ, Gomariz RP, Ganea D.Vasoactive intestinal peptide and pituitary activating polypeptide prevent inducible NO synthase transcription in macrophage by inhibiting nuclear factor-kappa B and IFN regulatory factor 1 activation. J Immunol1999; 168: 4685—4696.
19.
Sweet MJ, Hume DAEndotoxin signal transduction in macrophages. J Leukoc Biol1996; 60: 8—26.
20.
DeFranco AL , Crowley MT, Finn A., Hambleton J., Weinstein SLThe role of tyrosine kinases and map kinases in LPS-induced signaling. Prog Clin Biol Res1998; 397: 119—136.
21.
Yamamoto I. , Adachi T., Kishiro Y. et al. Interleukin-2-dependent augmentation of the anti-TNP antibody production by sodium butyrate in cultured murine splenic B cells. Int J Immunopharmacol1997 ; 19: 347—354.
22.
Yamamoto I. , Matsunaga T., Sakata K. et al. Histone hyper-acetylation plays a role in augmentation of IL-4 induced IgE production in LPS-stimulated murine B-lymphocytes by sodium butyrate. J Biochem (Tokyo) 1996; 119: 1056—1061.
23.
Kasukabe T. , Honma Y., Hozumi M.Induction of differentiation of cultured mouse monocytic leukemia cells (Mm-A) by inducers different from those of parent myeloblastic leukemia cell (M1). Jpn J Cancer Res1985; 76: 1056—1063.
24.
Wu GD, Huang N., Wen X., Keilbaugh SA, Yang H.High-level expression of I kappa B-beta in the surface epithelium of the colon: in vitro evidence for an immunomodulatory role. J Leukoc Biol1999; 66: 1049—1056.
25.
Perez R., Stevenson F., Johnson J. et al. Sodium butyrate upregulates Kupffer cell PGE2 production and modulates immune function. J Surg Res1998 ; 78: 1—6.
